全髋与全膝关节置换术后物理治疗达标治疗干预与常规物理治疗相比未改善结局:PATIO研究
这项全国性优效性整群随机对照试验将18家医院随机分配至达标治疗或常规物理治疗,纳入624例初次全髋或全膝关节置换患者。术后3个月,两组HOOS-PS与KOOS-PS变化评分均无统计学显著组间差异。结论认为个体化达标治疗物理治疗策略较常规物理治疗在全髋或全膝关节置换术后身体功能方面无额外获益。
要点
- 全髋与全膝关节置换术后3个月,达标治疗组与常规治疗组HOOS-PS和KOOS-PS变化评分无统计学显著差异。
- 所有组均显示显著且临床相关的功能改善。
- COVID-19大流行是潜在研究局限性,研究结果应谨慎解读。
核心结论
- 个体化达标治疗物理治疗策略在全髋或全膝关节置换术后身体功能方面较常规物理治疗无额外获益。
研究设计与样本
- 全国性优效性整群随机对照试验,18家医院随机分配至达标治疗或常规物理治疗,624例初次全髋或全膝关节置换患者符合参与条件。
- 评估在术前及术后6、12、24和52周进行。
- 主要结局为术后3个月身体功能变化,采用髋/膝损伤与骨关节炎结局评分-身体功能简表(HOOS-PS/KOOS-PS)评估。
- 组间比较采用边际模型,纳入医院作为固定效应,并调整社会人口学和临床特征。
- 纳入312例全髋关节置换(53%女性,年龄67岁(范围40至88))和312例全膝关节置换(55%女性,年龄67岁(范围41至88))。
主要发现
- 所有组均显示显著且临床相关的功能改善。
- 术后3个月随访时,HOOS-PS变化评分干预组为19.9(95%CI:17.8至22.1),对照组为18.2(95%CI:16.0至20.5),组间无统计学显著差异。
- 术后3个月随访时,KOOS-PS变化评分干预组为31.3(95%CI:29.3至33.4),对照组为31.1(95%CI:29.0至33.2),组间无统计学显著差异。
关键数值与推荐
- 主要结局为术后3个月HOOS-PS/KOOS-PS变化评分。
- HOOS-PS变化评分干预组19.9(95%CI:17.8至22.1) vs 对照组18.2(95%CI:16.0至20.5),组间无统计学显著差异。
- KOOS-PS变化评分干预组31.3(95%CI:29.3至33.4) vs 对照组31.1(95%CI:29.0至33.2),组间无统计学显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- COVID-19大流行是潜在研究局限性,研究结果应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This nationwide superiority cluster randomized controlled trial evaluated the effectiveness of a personalized, treat-to-target postoperative physical therapy (PPT) strategy compared to usual care after total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: There were 18 hospitals randomized to treat-to-target or usual PPT, with 624 patients undergoing primary THA or TKA being eligible for participation. Assessments were conducted preoperatively and at six, 12, 24, and 52 weeks after surgery. The primary outcome was change in physical functioning three months after surgery, assessed with the Hip/Knee injury Disability and Osteoarthritis Outcome Score-Physical Function Short Form (HOOS-PS/KOOS-PS). Comparisons between groups were done using marginal models, including hospital as a fixed effect, with adjustment for sociodemographic and clinical characteristics. There were 312 THAs (53% women, aged 67 years (range, 40 to 88)) and 312 TKAs (55% women, aged 67 years (range, 41 to 88)) included. The THA patients received, on average, around 20 PPT sessions, and TKA patients around 30 sessions. RESULTS: All groups showed significant and clinically relevant improvements in function. There were no statistically significant between-group differences in change scores found for either HOOS-PS (19.9 (95% confidence interval (CI): 17.8 to 22.1) in the intervention group versus 18.2 (95% CI: 16.0 to 20.5) in the control group) or KOOS-PS (31.3 (95% CI: 29.3 to 33.4) versus 31.1 (95% CI: 29.0 to 33.2), respectively) at 3-months follow-up. CONCLUSIONS: The use of a personalized treat-to-target PPT strategy had no additional benefits over usual PPT regarding physical functioning after THA or TKA. The COVID-19 pandemic is a potential study limitation; findings should therefore be interpreted with caution.
引用
- Groot L, Gademan MGJ, van Loon D, et al. PhysiotherApeutic Treat-To-Target Intervention After Total Hip and Knee Arthroplasty Does Not Improve Outcomes Compared to Usual Physical Therapy: The PATIO Study. J Arthroplasty. 2025. PMID: 41177186. doi:10.1016/j.arth.2025.10.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。